QID 590746

Date Published: 2022-07-29

QID 590746: Siemens Nucleus RTOS Transmission Control Protocol/Internet Protocol (TCP/IP) Stack Multiple Vulnerabilities (SSA-114589)

AFFECTED PRODUCTS
The following products and versions of the Nucleus RTOS are affected:
APOGEE MBC (PPC) (BACnet): All versions
APOGEE MBC (PPC) (P2 Ethernet): All versions
APOGEE MEC (PPC) (BACnet): All versions
APOGEE MEC (PPC) (P2 Ethernet): All versions
APOGEE PXC Compact (BACnet): All versions
APOGEE PXC Compact (P2 Ethernet): All versions
APOGEE PXC Modular (BACnet): All versions
APOGEE PXC Modular (P2 Ethernet): All versions

QID Detection Logic (Authenticated):
QID checks for the Vulnerable version of using passive scanning

Successful exploitation of these vulnerabilities could cause a denial-of-service condition, allow an information leakage, or remote code execution.

CVSS V3 rated as Critical - 9.8 severity.

CVSS V2 rated as High - 7.5 severity.

Solution

The vendor is planning to release fixes soon.
Customers are advised to refer to CERT MITIGATIONS section SSA-114589 for affected packages and patching details.

Vendor References

SSA-114589 - cert-portal.siemens.com/productcert/pdf/ssa-114589.pdf

CVEs related to QID 590746

CVE-2021-31344 | CVE-2021-31345 | CVE-2021-31346 | CVE-2021-31881 | CVE-2021-31882 | CVE-2021-31883 | CVE-2021-31884 | CVE-2021-31885 | CVE-2021-31886 | CVE-2021-31887 | CVE-2021-31888 | CVE-2021-31889 |

Software Advisories

Advisory ID	Software	Component	Link
SSA-114589			cert-portal.siemens.com/productcert/pdf/ssa-114589.pdf

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].